These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Venous thrombosis, oral contraceptives and high factor VIII levels. Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758 [TBL] [Abstract][Full Text] [Related]
3. The relative merits of risk ratios and odds ratios. Cummings P Arch Pediatr Adolesc Med; 2009 May; 163(5):438-45. PubMed ID: 19414690 [TBL] [Abstract][Full Text] [Related]
4. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305 [TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking and risk of cerebral sinus thrombosis in oral contraceptive users: a case-control study. Ciccone A; Gatti A; Melis M; Cossu G; Boncoraglio G; Carriero MR; Iurlaro S; Agostoni E Neurol Sci; 2005 Dec; 26(5):319-23. PubMed ID: 16388365 [TBL] [Abstract][Full Text] [Related]
6. Long-term use of oral contraceptives increases the risk of miscarriage. García-Enguídanos A; Martínez D; Calle ME; Luna S; Valero de Bernabé J; Domínguez-Rojas V Fertil Steril; 2005 Jun; 83(6):1864-6. PubMed ID: 15950668 [TBL] [Abstract][Full Text] [Related]
7. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Pomp ER; Rosendaal FR; Doggen CJ Am J Hematol; 2008 Feb; 83(2):97-102. PubMed ID: 17726684 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and risk of colorectal cancer. Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422 [TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use. Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454 [TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS). Contraception; 1997 Nov; 56(5):275-84. PubMed ID: 9437555 [TBL] [Abstract][Full Text] [Related]
15. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives? Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798 [TBL] [Abstract][Full Text] [Related]
17. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis? Sapp AV; Lindbloom EJ J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894 [No Abstract] [Full Text] [Related]
18. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the risk difference, risk ratio and odds ratio scales for quantifying the unadjusted intervention effect in cluster randomized trials. Ukoumunne OC; Forbes AB; Carlin JB; Gulliford MC Stat Med; 2008 Nov; 27(25):5143-55. PubMed ID: 18613226 [TBL] [Abstract][Full Text] [Related]
20. Measures of association in clinical trials: definition and interpretation. Carneiro AV Rev Port Cardiol; 2003 Nov; 22(11):1393-401. PubMed ID: 14768494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]